Hansoo Park

7PUBLICATIONS
18CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)BiodiscoveryPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 11, 2024
Contactin-4 suppresses antitumor T cell responses by engaging amyloid precursor protein.

Bu-Nam Jeon, Sujeong Kim, Yunjae Kim

|Apr 25, 2023
Intracellular Adhesion Molecule-1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8+ T Cells.

Se-Hoon Lee, Yeongmin Kim, Bu-Nam Jeon

|Jun 21, 2022
Staphylococcus epidermidis WF2R11 Suppresses PM2.5-Mediated Activation of the Aryl Hydrocarbon Receptor in HaCaT Keratinocytes.

Eulgi Lee, Hyeok Ahn, Shinyoung Park

|Aug 11, 2021
Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts.

Deukchae Na, Jeesoo Chae, Sung-Yup Cho

|Mar 30, 2021
A review on the role of gut microbiota in immune checkpoint blockade therapy for cancer.

Esther Kim, Hyeok Ahn, Hansoo Park

|Feb 20, 2021
Spermidine-induced recovery of human dermal structure and barrier function by skin microbiome.

Gihyeon Kim, Misun Kim, Minji Kim

Pageof 2

Frequent Collaborators

2 joint publications

Gihyeon Kim

1 joint publications

Myeong Hee Moon

1 joint publications

George M Weinstock

1 joint publications

Yeong-Geun Lee